Faculty

Needs Statement

Addiction affects 10-20% of the population without prejudice to race, sex, income, or age. With the increasing death rate due to legal prescriptions and drugs manufactured illegally, dentists and dental hygienists need to incorporate the ADA policy on opiates into their practice to address the problem. They also need to know if medical marijuana is a viable alternative for pain management.

Target Audience

Dentists and dental hygienists in all practice settings.

Objectives

Upon completion of this educational activity, particpants will be able to:

• Discuss dentistry's role in the epidemic
• Discuss the effect of legalized marijuana in Colorado
• Review prescribing practices to be part of the solution

Accreditation

Other
UK Healthcare CECentral certifies this activity for 0.75 hours of participation.

CDE
This online course meets regulatory requirements for 0.75 hours credit as permitted by 201 KAR 8:532 for dentists and 201 KAR 8:562 for dental hygienists.

Faculty Disclosure

No speaker or other planners have any relevant financial relationships to disclose.

The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speaker. In some cases, the presentation might include discussion of investigational agents and/or off-label indications for various agents used in clinical practice. The speaker will inform the audience when they are discussing investigational and/or off-label uses.

Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.

Acknowledgement

This activity is jointly provided by the University of Kentucky and Kentucky Injury Prevention and Research Center University of Kentucky College of Public Health (KIPRC).

CE Content Concerns

Policy

Concerns or complaints related to ACPE or ACCME standards may be submitted in writing to the Director of UK HealthCare CECentral by fax to 859-323-2920, or by mail to 2365 Harrodsburg Road, Ste B475, Lexington, KY 40504

Procedures

• The Director or his/her designee will review, investigate, forward and/or respond to complaints and will put forth a best effort to adjudicate the issue(s), along with CECentral staff members, within two (2) weeks of receipt of the grievance or complaint.
• If needed, concerns, complaints, or grievances will be brought before the UK HealthCare CECentral Advisory Board.
• Issues regarding activity content also will be reviewed and addressed by the Activity Director.
• A written decision will be issued in a timely manner by the Director of UK HealthCare CECentral or his/herdesignee.
• Grievances will be considered when planning future activities.

Appeal Procedure

• Persons who wish to appeal a decision should address the appeal by email, fax or in writing to the Director of UK HealthCare CECentral within two (2) weeks of receipt of the response.
• The Director will bring the appeal to the UK HealthCare CECentral Advisory Board.
• The results of the appeal will be sent to the participant no later than two (2) weeks following the meeting of the board.